Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/5/24 16:59 | 6/3/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Gilbert Halley E | CA | D | 1 | S.d | -1,329 | 73.00 | 0 | -18 | 6 | D | ||||||||||||||||
6/5/24 16:58 | 6/3/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Eydelman Mikhail | CA | O | SVP,GC,C | 8 | S.d | -2,260 | 56.49 | 0 | -40 | 31 | D | |||||||||||||||
6/5/24 16:57 | 6/3/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Wassil Jim | CA | O | COO | 10 | S.d | -1,843 | 61.45 | 0 | -30 | 219 | D | |||||||||||||||
6/5/24 16:56 | 6/3/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Pickering Grant | CA | DO | CEO | 18 | S.dm | -13,149 | 63.78 | 0 | -206 | 775 | I | |||||||||||||||
5/22/24 17:03 | 5/20/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Guggenhime Andrew | CA | O | P,CFO | 9 | S.d | -4,825 | 61.86 | 0 | -78 | 96 | D | |||||||||||||||
3/4/24 21:22 | 3/1/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Cowan Elvia | CA | O | SVP,Fina | 1 | S.d | -865 | 74.08 | 0 | -12 | 12 | D | |||||||||||||||
2/2/24 16:40 | 1/31/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Lukatch Heath | CA | D | 3 | S.d | -1,456 | 66.20 | 0 | -22 | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |